Major investors lining up behind embattled GlaxoSmithKline chief

Major investors lining up behind embattled GlaxoSmithKline chief Emma Walmsley in her fight with activist investor Elliott Management By Alex Lawson And Emma Dunkley, Financial Mail On Sunday Published: 21:50 BST, 3 July 2021 | Updated: 21:50 BST, 3 July 2021 Major investors are lining up behind embattled GlaxoSmithKline chief Emma Walmsley in her fight … Read more

Covid UK: GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax vaccine

Boris Johnson tonight revealed GlaxoSmithKline will support the manufacturing of up to 60million doses of the Novavax coronavirus vaccine in the UK. No10’s vaccines taskforce has signed a deal with British drugs giant GSK to ‘fill and finish’ supplies of the American jab at its factory in Durham starting from May. Mr Johnson said the move … Read more

UK signs deal with GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax’s Covid vaccine

The Government has agreed a deal with pharmaceutical giant GlaxoSmithKline (GSK) on the manufacture of up to 60 million doses of the Novavax coronavirus vaccine. Here is what we know: – How does the vaccine work? The Novavax vaccine works like other vaccines by teaching the immune system to make antibodies to the coronavirus spike … Read more

GlaxoSmithKline sacks US vaccine tsar over sexual harassment claims

GlaxoSmithKline sacks US vaccine programme boss over sexual harassment allegations By Matt Oliver For The Daily Mail Published: 21:50 GMT, 24 March 2021 | Updated: 21:50 GMT, 24 March 2021 A GlaxoSmithKline executive who was poached to run the US vaccines programme has been fired by the British company over sexual harassment allegations. Moncef Slaoui, … Read more

GlaxoSmithKline slumps as it diverts dividend cash to drugs pipeline

GlaxoSmithKline slumps as it diverts dividend cash to feed drugs pipeline amid profits warning By Matt Oliver For The Daily Mail Published: 21:50 GMT, 3 February 2021 | Updated: 21:50 GMT, 3 February 2021 Shares in Glaxosmithkline sank by Matt Oliver after it warned profits would fall and that it plans to cut the dividend … Read more

GlaxoSmithKline gets booster from £100m drug deals spree

Pharma giant GlaxoSmithKline set to cap a £100m spending spree with two major drug deals either side of Atlantic By Alex Lawson, Financial Mail On Sunday Published: 21:53 GMT, 19 December 2020 | Updated: 22:28 GMT, 19 December 2020 Pharma giant GlaxoSmithKline is this week set to cap a £100million spending spree with two major … Read more

GlaxoSmithKline begins coronavirus vaccine trials

GlaxoSmithKline steps up battle against Covid-19 with clinical trials of potential vaccine it is developing with French drug maker Sanofi By Daily Mail City & Finance Reporter Published: 22:25 BST, 3 September 2020 | Updated: 22:25 BST, 3 September 2020 GlaxoSmithKline has stepped up its battle against Covid-19 with clinical trials of a potential vaccine … Read more

Pharmaceutical firms GlaxoSmithKline and Sanofi launch human trials of promising coronavirus vaccine

Drug companies GlaxoSmithKline (GSK) and Sanofi are joining the race to discover a Covid-19 vaccine and starting human clinical trials this week.   The pharmaceutical giants have enrolled more than 400 people for the phase one and two trial, which will assess the safety of the vaccine candidate.  The UK Government signed a deal with the … Read more

Glaxosmithkline pledges 1 billion doses of Covid-19 vaccine booster

Glaxosmithkline pledges 1 billion doses of special chemical to improve effectiveness of Covid-19 vaccines By Matt Oliver For The Daily Mail Published: 21:51 BST, 28 May 2020 | Updated: 22:12 BST, 28 May 2020 Glaxosmithkline has delivered a major boost in the search for Covid-19 vaccines, vowing to pump out one billion doses of a … Read more

Glaxosmithkline pins hopes on vaccines pipeline

Glaxosmithkline pins hopes on vaccines pipeline after shingles jab generates blockbuster sales By Alex Brummer for the Daily Mail Published: 22:35 BST, 14 January 2020 | Updated: 22:35 BST, 14 January 2020 Glaxosmithkline is well advanced in developing a suite of vaccines which will guard against respiratory viruses in children and lung diseases in adults … Read more